Research Article
Efficacy of Definitive Radiotherapy for Patients with Clinical Stage IIIB or IIIC Lung Adenocarcinoma and Epidermal Growth Factor Receptor (EGFR) Mutations Treated Using First- or Second-Generation EGFR Tyrosine Kinase Inhibitors
Figure 3
Overall survival curve (in years) showing no significant difference between the RT and non-RT groups in the primary analysis after overlap weights adjustment. RT, radiotherapy.